“UNAIDS is greatly concerned about the lack of progress for people who inject drugs, which is due to the failure of many countries to implement evidence-informed, human rights-based approaches to drug use,” said Michel Sidibé, Executive Director of UNAIDS, the UN agency dedicated to combatting the virus.
The new UNAIDS report, Health, rights and drugs: harm reduction, decriminalization and zero discrimination for people who use drugs, shows that of the 10.6 million who injected drugs in 2016, more than half were living with hepatitis C and one-in-eight with HIV.
Among other things, comprehensive harm reduction services, such as needle–syringe programmes, drug dependence treatment and HIV testing and treatment would “kick-start progress on stopping new HIV infections among people who use drugs”, says the report.
“By putting people at the centre and ensuring that they have access to health and social services with dignity and without discrimination or criminalization,” Mr. Sidibé said, “lives can be saved and new HIV infections drastically reduced”.
Few UN Member States have lived up to an agreement made at the 2016 Special Session on the World Drug Problem, to establish effective measures for people who use drugs, according to the agency.
UNAIDS advocates for the full engagement of civil society as an essential source of information and advocacy, especially in places where repressive policies and practices are the norm.
The organization also promotes human rights and health services, targeting harm reduction and HIV services, community-led responses and the removal of drug- and HIV-related stigmas and discrimination.
UNAIDS recommendations:
- Implement harm reduction and HIV services, including opioid substitution therapy and overdose management.
- Ensure that all drug users have access to prevention, testing and treatment for HIV, tuberculosis and sexually transmitted infections.
- Decriminalize drug possession and personal use.
- Act to eliminate all forms of stigma and discrimination experienced by people who use drugs.
- Support civil society’s full engagement as a source of information and to provide community-led services.
- Invest in human rights programmes and health services.